OLMESARTAN AMLODIPIN HCT Zentiva 20/5/12.5 28 pce
7680683270018
CH-68327
C09DX03
02.07.2.
Reimbursement limitations:
OLMAMLZENTIV
Le traitement combiné d'Olmésartan Amlodipin HCT Zentiva et d'un antagoniste du calcium I.T. 02.06. et/ou …
1 / 3
google
Details
- Product number
- 6832701
- CPT
- -
- Packaging group
- 28
- Unit
- Tablette(n)
- Composition
- Filmtablette: olmesartanum medoxomilum 20.000 mg, amlodipinum 5.000 mg ut amlodipini besilas, hydrochlorothiazidum 12.500 mg, povidonum K 30, amylum pregelificatum, cellulosum microcristallinum silicificatum, lactosum monohydricum 10.000 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum, talcum, E 172 (flavum), E 172 (nigrum), E 172 (rubrum), pro compresso obducto.
Articles (1)
Olmesartan Amlodipin HCT Zentiva 20 mg/5 mg/12.5 mg, Filmtabletten
Filmtabletten
28
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
FTAB
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
FTAB
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
FTAB
|
- | Substance | WIZUS |
|
FTAB
|
12.5 MG | Substance | Wirkstoff (Principe actif) |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
10.0 MG | Substance | HBESI |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | FNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | FTODK |
|
FTAB
|
- | Substance | FTODK |
|
FTAB
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 33.75
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/05/2022
Authorization holder
Helvepharm AG
8500 Frauenfeld
Authorization information
- Swissmedic authorization number
- 68327
- Drug name
- Olmesartan Amlodipin HCT Zentiva, Filmtabletten
- Galenic form
- FILM
- ATC Code
- C09DX03
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 19/08/2021
- Authorization expiration date
- 18/08/2026
- IT number
- 02.07.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- OLMESARTAN AMLODIPIN HCT Zentiva 20/5/12.5 28 pce
- Description (DE)
- OLMESARTAN AMLODIPIN HCT Zentiva 20/5/12.5 28 Stk
- Market launch
- 19/08/2021
- Narcotic (BTM)
- No